top of page
Speaker at Boston CEO · November 2–3, 2026
Tim Ehrlich

Tim Ehrlich

Partner

Gunderson Dettmer

As the head of the firm’s Life Sciences practice group, Tim represents start-up, emerging growth and public life science companies in the biotechnology, pharmaceutical, medical device, diagnostics and healthcare IT industries. His practice spans the entire corporate lifecycle, from formation through liquidity, and he regularly serves as principal outside or general counsel to his clients. Tim also has particular expertise in structuring and negotiating strategic alliances, including “bet-the-company” intellectual property collaborations and joint ventures, and providing strategic counseling and advice regarding intellectual property protection and commercialization. In addition to his company client counsel, Tim represents venture capital funds and institutional investors in their life science financing activities.

bottom of page